Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma

BACKGROUND: Budesonide/formoterol is an effective treatment for both asthma and chronic obstructive pulmonary disease. This study compared the efficacy and safety of a novel hydrofluoroalkane (HFA) pressurised metered-dose inhaler (pMDI) formulation of budesonide/formoterol with that of budesonide p...

Descripción completa

Detalles Bibliográficos
Autores principales: Morice, A H, Peterson, S, Beckman, O, Osmanliev, D
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228375/
https://www.ncbi.nlm.nih.gov/pubmed/17887990
http://dx.doi.org/10.1111/j.1742-1241.2007.01574.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228375/
https://www.ncbi.nlm.nih.gov/pubmed/17887990
http://dx.doi.org/10.1111/j.1742-1241.2007.01574.x

Ejemplares similares